SEGMENT INFORMATION

6 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

NOTE 8:- SEGMENT INFORMATION

a. The Company had three reporting segments until the spin-off of Shagrir (see note 1), while the RSA segment was related to Shagrir's operation. Following the spin-off the Company operates with two reporting segments. The following segment identification is identical to the segment used in the latest annual consolidated financial report.

b. The following presents segment results of operations for the six months ended June 30, 2016 (unaudited):

	Cellocator segment		MRM  segment		Elimination		Total
Segments revenues	$	11,193	$	23,685	$	(3,838)	$	31,040
Segments operating profit	$	772	$	2,351	$	104	$	3,227
Segments tangible and intangible assets	$	8,431	$	25,627	$	2,162	$	36,220
Depreciation and amortization	$	166	$	964	$	-	$	1,130
Expenditures for assets	$	51	$	1,078	$	-	$	1,129

c. The following presents segment results of operations for the six months ended June 30, 2015 (unaudited): 

	Cellocator segment		MRM  segment		Elimination		Total
Segments revenues	$	11,009	$	22,484	$	(2,590)	$	30,903
Segments operating profit	$	1,243	$	1,717	$	185	$	3,145
Segments tangible and intangible assets	$	8,758	$	26,926	$	3,179	$	38,863
Depreciation and amortization	$	171	$	1,175	$	-	$	1,346
Expenditures for assets	$	79	$	906	$	-	$	985

d. The following presents segment results of operations for the three months ended June 30, 2016 (unaudited):

	Cellocator segment		MRM  segment		Elimination		Total
Segments revenues	$	5,591	$	12,248	$	(1,625)	$	16,214
Segments operating profit	$	166	$	1,438	$	41	$	1,645
Segments tangible and intangible assets	$	8,431	$	25,627	$	2,162	$	36,220
Depreciation and amortization	$	83	$	530	$	-	$	613
Expenditures for assets	$	31	$	476	$	-	$	507

e. The following presents segment results of operations for the three months ended June 30, 2015 (unaudited):

	Cellocator  segment		MRM  segment		Elimination		Total
Segments revenues	$	5,545	$	11,124	$	(1,178)	$	15,491
Segments operating profit	$	612	$	730	$	69	$	1,411
Segments tangible and intangible assets	$	8,758	$	26,926	$	3,179	$	38,863
Depreciation and amortization	$	85	$	584	$	-	$	669
Expenditures for assets	$	50	$	466	$	-	$	516

f. The following presents segment results of operations for the year ended December 31, 2015:

	Cellocator  segment		MRM  segment		Elimination		Total
Segments revenues	$	19,489	$	47,938	$	(6,860)	$	60,567
Segments operating profit (loss)	$	1,000	$	3,848	$	(205)	$	4,643
Segments tangible and intangible assets	$	8,469	$	24,836	$	1,804	$	35,109
Depreciation, amortization and impairment expenses	$	338	$	3,067	$	-	$	3,405
Expenditures for assets	$	149	$	1,647	$	-	$	1,796